Resultados de la búsqueda 111-120 of 16036 for pancreatic disease
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) ... pancreatic ductal adenocarcinoma (PDAC).
standard chemotherapy alone in patients with oligometastatic pancreatic cancer. ... PFS is defined as the time from randomization to the first of either disease ...
... disease. Evaluating Markers which Might be a Predictor of Pancreatic Cancer or Precancer by Analyzing the Secretions (fluid) from a Pancreatic cyst.
... Pancreatic Cancer and Peritoneal Metastasis. Rochester, Minn. The primary purpose of this study is to assess short-term morbidity and disease-free survival ...
... disease progression and CA19-9 level in Pancreatic Ductal Adenocarcinoma (PDAC) patients and is a reliable biomarker of response. A Study to Collect ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... Pancreatic SPORE, “Optimal ...
... Pancreatic Cancer” (Principal Investigator Dr. ... disease following an attempt to perform ... Most newly-diagnosed CLL patients have early-stage disease at the ...
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... Pancreatic Cancer Therapies.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?